The Institute for Patient Access is a physician-led policy research organization dedicated to maintaining the primacy of the physician-patient relationship in the provision of quality health care.

POLICY TOPICS

What's New on the Blog

Embracing Biosimilars

July 13, 2021

I know some people who are brand loyal because they are hesitant to change. I, however, am not one of them. And I take that approach in prescribing biologics and biosimilars for my patients, too.

ICER Crosses the Center Line

July 9, 2021

The admonition to the Institute for Clinical and Economic Review’s Beacon Hill economists should be quite simple: “Stay in your lane.”

Latest

Biosimilars: Expanding Options for Cancer Care
A Path to Hepatitis C Elimination for Policymakers
Fast Facts: Center for Medicare and Medicaid Innovation
Seventh Annual Summit on Balanced Pain Management
National Policy & Advocacy Summit on Biologics